Navigation Links
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Date:1/28/2010

WHITEHOUSE STATION, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection).  ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.  With the EC approval, Merck receives marketing authorization for ELONVA with unified labeling valid in all European Union Member States. Schering-Plough Corp. and Merck & Co., Inc. merged on Nov. 3, 2009.  

ELONVA is the first sustained follicle stimulant.  Due to its ability to initiate and sustain multiple follicular growth for an entire week, a single subcutaneous injection of the recommended dose of ELONVA may replace the first seven injections of any conventional daily recombinant follicle stimulating hormone (rFSH) preparation in a COS treatment cycle.

"The European approval of ELONVA is a positive step towards reducing the burden of injections for women experiencing difficulty conceiving," said Mirjam Mol-Arts, senior vice president, Merck Research Laboratories. "Merck is proud of the company's women's health portfolio and is committed to providing effective patient-focused fertility treatments."  

The Phase III development program for ELONVA included the Engage trial, the largest double-blind fertility agent trial in IVF performed to date.  In the Engage trial, the ongoing pregnancy rate, the primary endpoint, obtained in the ELONVA treatment arm (38.9 percent per started cycle) was similar to that achieved in patients receiving a daily dose of rFSH (38.1 percent per started cycle).
'/>"/>

SOURCE Merck & Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
2. CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
3. Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
4. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
5. Merck Seronos Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinsons Disease in a Phase III Pivotal Trial
6. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
7. Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
8. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
9. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
10. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
11. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015  Cardinal Health has been named one ... Women " by the National Association for Female Executives ... successful women. "We,re counting the numbers ... and are happy to find that companies are responding ... NAFE President. "The 2015 NAFE Top Companies demonstrate their ...
(Date:3/3/2015)... -- Mapi incorporates the expertise of CanReg ... development and commercialization process. Mapi Group ... with the addition of the CanReg Group, incorporated into ... is one of North America,s ... life sciences companies. With nearly 100 consultants, advisors and ...
(Date:3/3/2015)... 2015  Blueprint Medicines today announced a strategic ... novel drug candidates for an undisclosed activated kinase ... genetic disease. Blueprint Medicines will apply its kinase-focused ... candidates and will conduct all research activities prior ... (IND) application with the Food and Drug Administration. ...
Breaking Medicine Technology:Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 2Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 3Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE 4Mapi incorporates Strategic Regulatory Services to support life-science product Commercialization and Health Research 2Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease 2
... WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ... and the Integrated BioBank of Luxembourg (IBBL) today announced ... expand the use of the WaferGen SmartChip Real-Time PCR ... The agreement includes: The purchase ...
... BUDAPEST, HUNGARY, Dec. 16, 2010 Watson Pharmaceuticals, Inc. ... Plc ("Richter") today announced that Watson,s subsidiary, Watson Laboratories, ... PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, ... U.S. and Canada.  In European studies, Esmya™ has been ...
Cached Medicine Technology:WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 2WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 3WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 4WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 5Watson and Richter Announce Exclusive License Agreement for Esmya™ 2Watson and Richter Announce Exclusive License Agreement for Esmya™ 3Watson and Richter Announce Exclusive License Agreement for Esmya™ 4Watson and Richter Announce Exclusive License Agreement for Esmya™ 5
(Date:3/3/2015)... Using an “intelligent,” rather than random, ... D prescription drug coverage plans could save Medicare and ... of Pittsburgh Graduate School of Public Health analysis discovered. ... issue of the journal Health Affairs and build upon ... more than $5 billion in its Part D low-income ...
(Date:3/3/2015)... Perth Amboy, NJ (PRWEB) March 03, 2015 ... the winners of “Picture of Health,” an interactive photo ... NJ on Sunday, February 8, 2015. To raise awareness ... community, visitors were encouraged to share their best health ... tips appeared on Raritan Bay Medical Center’s website and ...
(Date:3/3/2015)... 03, 2015 Chicago has long been known ... Michael Jordan, brought a level of basketball to Chicago that ... experience again since his Chicago Bulls days in the 1990’s. ... to this day. This era also witnessed the birth and ... Due to this rich basketball culture, US Sports Camps seeks ...
(Date:3/3/2015)... 03, 2015 Volpara Solutions, leaders in ... John D. Pavlidis has joined their Board of Directors. ... and executive management experience in the medical industry, including ... small organizations. , “John’s broad management experience in breast ... will be a tremendous asset to the sales, product ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Nutritional ... an international keynote presenter at the third ecommerce ... Melbourne Convention and Exhibition Centre March 10-12. , ... March 11, at 11 am (Melbourne time). His ... Interests,” will discuss making each customer’s experience unique ...
Breaking Medicine News(10 mins):Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 2Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 3Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2
... be the hardest hit as a result of the recent ... events. Approximately 23 percent of Japanese citizens currently are age ... proportion of older people in any country gives us ... headed," said James Appleby, RPh, MPH, executive director of The ...
... with different terms to describe a clinical trial, parents were far ... called a "research study" than if it was called a "medical ... the former as safer, even though that was not necessarily the ... Human Research . Terms such as these are ...
... HealthDay Reporter , THURSDAY, March 17 (HealthDay News) -- ... known: pimples, low self-esteem and depression often go hand-in-hand. ... emotional problems, the analysis of 16 studies suggests that ... sales. "Acne has a huge impact on people,s ...
... , FRIDAY, March 18 (HealthDay News) -- The ... of Americans now infected with HIV, a new report suggests. ... and experienced in providing the care these patients need, the ... third and final report of a series focused on the ...
... delivering on its commitment to help the world,s most ... affordable, reliable, and stable treatment for malaria that will ... children in Africa. The Honourable Gary Goodyear, Minister of ... Trost, Member of Parliament for SaskatoonHumboldt, announced the breakthrough ...
... physicians of patients who drive with cognitive impairment, according ... , the official journal of the American Gastroenterological Association ... of patients with cirrhosis (a condition in which the ... and diseases) are affected by a peculiar kind of ...
Cached Medicine News:Health News:Japanese tsunami underscores need for elder disaster preparedness 2Health News:Terminolgy matters in parents' willingness to enroll their children in research 2Health News:Acne May Blemish Teens' Emotional Lives, Too 2Health News:Report Highlights Shortage of HIV Care Providers in U.S. 2Health News:Government of Canada announces results in fight to save women and children with malaria 2Health News:Doctors should evaluate liver disease patients for cognitive impairment, address driving safety 2Health News:Doctors should evaluate liver disease patients for cognitive impairment, address driving safety 3
... Craftsmanship have produced the finest ... Ocutek now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Craftsmanship have produced the finest ... Ocutek now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: